Enliven Therapeutics Inc (NASDAQ: ELVN) – Not A Clear Buying Opportunity?
Enliven Therapeutics Inc (ELVN) concluded trading on Wednesday at a closing price of $21.57, with 0.42 million shares of worth about $9.14 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.83% during that period and on June 18, 2025 the price saw a […]
These Numbers Could Change Investor Views For Enliven Therapeutics Inc (NASDAQ: ELVN)
Commodore Capital LP recently announced the acquisition of new stake in Enliven Therapeutics Inc (NASDAQ:ELVN). The institutional investor has increased its shareholding in the Healthcare company by 23.57% to 2.9 million shares with purchase of 0.55 million shares. This fresh investment now brings its stake to 7.04% valued currently at $32.67 million. In addition, Citadel […]